Investors
Aims to globally expand as a research-oriented pharmaceutical company
with platforms and incrementally modified drugs.
Global Market Development
Expand global business by extending the number of licensed overseas partners to cooperate.
Continuous Pipeline Excavation
Develop drug substances and incrementally modified drugs with accumulated experience and database to plan and launch new products sequentially.
Distinctive Technology Development
Through R&D investment, discover highly marketable products and evaluate technology analysis.
